Two engines are finally pulling AMETEK
- Q1 2026 sales rose 11.3% to $1.93 billion, helped by 5% organic growth and recent acquisitions.
- The big shift is EIG turning positive again, with 2% organic growth after weakness in 2025.
- EMG stayed very strong, with record Q1 sales of $663.9 million and 11% organic growth.
- The company ended Q1 with a record $3.87 billion backlog, giving better sales visibility for 2026.
- The main worry is not demand right now, but whether acquisitions can lift margins fast enough.
A cleaner two-part recovery
AMETEK looks healthier than it did through much of 2025. In Q1 2026, total sales grew 11.3% to $1.93 billion. Organic growth, which means growth before acquisitions and currency moves, was 5%. That matters because it shows customers are buying more, not only that AMETEK bought more companies.
The best change is in Electronic Instruments Group, or EIG. This is AMETEK's larger segment, and it had been a weak spot. In Q1, EIG returned to 2% organic growth, while acquisitions added another 7%. That makes the recovery look more real than it did when EIG growth was mostly bought through deals.
Electromechanical Group, or EMG, is still the stronger engine. Its Q1 sales reached a record $663.9 million, up 12.9%, with 11% organic growth. Together, EIG and EMG give AMETEK a broader growth base than it had a year ago.
The page is not a victory lap. AMETEK's quality and deal record are widely known, so the stock has to keep earning its price. The next test is margin execution, especially in EIG, where recent acquisitions hurt operating margin by 140 basis points, or 1.4 percentage points, in Q1.
Buy niche leaders, improve them
AMETEK makes high-value parts and instruments that customers use in hard jobs. Many products measure, test, control, connect, or move something important. If a plant, aircraft, power system, or medical device depends on accuracy, AMETEK wants to sell the tool behind that accuracy.
The company runs a decentralized model. That means many smaller business units operate close to their customers, while the parent company pushes cost control, pricing, product development, and capital discipline. AMETEK also buys niche technology companies, then tries to raise their margins over time.
This model can work well because customers often care more about reliability than the lowest price. The weakness is clear too. If AMETEK overpays for deals, cannot integrate them, or buys businesses with lower margins for too long, the compounding story slows.
Precise tools for hard jobs
Process and analytical instruments
These EIG products monitor, test, calibrate, and analyze industrial processes. They tend to matter most where accuracy, uptime, and safety are important.
Aerospace and power products
AMETEK sells instruments and engineered components into aerospace and power markets. These markets can be cyclical, but customer requirements are often strict.
Automation and engineered solutions
EMG includes motors, motion control systems, thermal management products, specialty metals, and electrical interconnects. This group delivered 11% organic growth in Q1 2026.
FARO 3D measurement and imaging
FARO joined EIG after the July 2025 acquisition. Its portable measurement arms, laser scanners, and trackers add exposure to 3D measurement and inspection.
LKC ophthalmic technology
LKC Technologies was acquired in February 2026. It adds tools used in the diagnosis and management of eye conditions, widening AMETEK's medical technology reach.
EIG is larger, EMG is faster
Segment mix is based on Q1 2026 sales: EIG at $1.26 billion and EMG at $663.9 million. EIG is the larger business, while EMG is currently growing faster organically.
What could break the story
EIG recovery fades
High impact · Medium oddsEIG returned to 2% organic growth in Q1 2026, but one quarter does not prove a full cycle recovery. If core EIG demand weakens again, the company could look more dependent on acquisitions for growth.
Acquisition margins stay diluted
High impact · Medium oddsAMETEK's model depends on buying smaller technology businesses and improving them. In Q1 2026, recent acquisitions reduced EIG operating margin by 140 basis points, or 1.4 percentage points. If that drag lasts, earnings growth may lag sales growth.
Industrial slowdown hits both engines
Medium impact · Medium oddsAMETEK sells into many industrial, aerospace, power, and medical markets. That spread helps, but it does not make the company immune to a global slowdown. Weaker customer budgets could hurt orders and backlog conversion.
Input costs and supply problems return
Medium impact · Medium oddsAMETEK depends on specialized materials, components, and global operations. Raw material shortages, higher costs, or geopolitical disruption can pressure production schedules and margins.
Valuation leaves less room for mistakes
Medium impact · Medium oddsAMETEK is a high-quality industrial compounder, and investors often price it that way. If growth slows or acquisition returns disappoint, the stock may not get much patience.
In one breath
What does AMETEK actually make?
AMETEK makes electronic instruments and electromechanical devices. In plain English, it sells tools that measure, test, monitor, connect, control, or move things in industrial, aerospace, power, and medical settings.
Why does AMETEK buy so many companies?
Acquisitions are central to its model. AMETEK buys niche technology businesses, adds them to its decentralized structure, and tries to improve sales, costs, and margins over time.
What changed most in 2026?
EIG, the larger segment, returned to positive organic growth in Q1 2026. That joined the strong growth already happening in EMG, making the company less dependent on one segment.
What is the biggest thing to watch next?
Watch EIG margin recovery. Recent deals helped sales, but they also diluted EIG operating margin in Q1, so the key question is whether AMETEK can raise those acquired margins.